Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Dermatology
•
Pediatric Dermatology
What is your treatment approach to biopsy-confirmed chronic lichen nitidus in an adult recalcitrant to topical steroids, topical calcineurin inhibitors, and topical ruxolitinib?
Related Questions
How do you manage atopic dermatitis in pediatric patients who has failed dupilumab?
How do you counsel families of pediatric patients on methotrexate about live vaccine schedules?
What is your recommended dosing regimen for propranolol in treating an infantile hemangioma after the proliferative phase?
Would you recommend continuing Accutane in a teenage female who has experienced a drop in calcium to 8.8 and reductions in albumin and protein levels one month into therapy?
In the era of targeted therapies, are there any specific cytokines that help guide therapy?
How do you determine the need to biopsy subcutaneous nodules in infants to rule out Infantile myofibromatosis?
What workup do you recommend for pediatric patients with telogen effluvium?
What therapies have you had success with in treating CARP when they have failed minocycline?
What are the best biologics for a pediatric patient with extensive guttate psoriasis that is poorly controlled on topicals?
How would you manage a patient with profound hyperpigmentation of the face and neck which is attributed to a post-COVID vaccine reaction?
